397.70999 USD
0.367
0.09%
Last update Dec 16, 3:33 PM GMT
Market closed
Day range
390.67990
397.70999
Previous close
397.34299
Open
390.67990
Access this stock data via API
Subscribe
Alnylam Pharmaceuticals Inc.
397.71
0.37
0.09%

Financials

Income statement

Fundamentals currency is IDR
Fiscal date 2021 2020 2019 2018
Total reported revenue 5.7T 4.0T 7.2T 7.1T
Cost of revenue 2.9T 2.0T 3.1T 3.0T
Gross profit 2.8T 1.9T 4.1T 4.1T
Operating expense
Research & development
Selling general and admin 233.6B 170.8B 278.9B 275.2B
Other operating expenses 10.9B 15.9B 12.4B 11.8B
Operating income 2.3T 1.5T 3.5T 3.5T
Non operating interest income
Income 136.9B 202.3B 280.7B 237.5B
Expense 308.2B 197.7B 219.7B 243.3B
Other income expense
Pretax income 1.6T 1.1T 3.3T 2.9T
Tax provision 13.8B 29.9B 30.9B 26.9B
Net income 1.6T 1.1T 3.2T 2.8T
Basic EPS 28.7 19.3 56.5 52.8
Diluted EPS 28.7 19.3 56.5 52.8
Basic average shares 48.2B 48.2B 48.2B 48.2B
Diluted average shares 48.2B 48.2B 48.2B 48.2B
EBITDA 2.1T 1.4T 3.5T 3.1T
Net income from continuing op.
Minority interests -167.9B -189.2B -520.3B -284.1B
Preferred stock dividends 0 0 0 0
Access /income_statement data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 17 minutes

06:57
00:00
08:00
16:30
23:59

Trading Hours (Monday - Friday):

Pre-market
07:15 - 08:00
Main market
08:00 - 16:30
Post-market
16:30 - 17:15
All times are displayed in the Europe/London timezone (GMT, UTC+00:00).